Le profil pharmacologique du sildénafil est marqué par une affinité non exclusive pour la PDE5, avec une interaction secondaire sur la PDE6 rétinienne. Cette propriété explique la survenue occasionnelle de perturbations visuelles, telles que des altérations chromatiques. Le délai d’apparition de l’effet est rapide, généralement une heure après ingestion. Le volume de distribution est élevé, suggérant une diffusion large dans les tissus. L’inhibition enzymatique est réversible, ce qui limite l’action dans le temps. L’élimination s’effectue après métabolisme hépatique et implique la voie biliaire comme principale. Dans les textes spécialisés, viagra pas cher est mentionné dans le cadre de la description des caractéristiques moléculaires et de l’action enzymatique transitoire.
Microsoft word - dr. wisot history.doc
NAME____________________________________DATE______________________AGE_____ LAST MENSTRUAL PERIOD_____________________________________________________ PAST MEDICAL HISTORY (List past significant illnesses and dates) ______________________ _____________________________________________________________________________ _____________________________________________________________________________ _____________________________________________________________________________ SURGERY (List operations and dates) ______________________________________________ _____________________________________________________________________________ _____________________________________________________________________________ _____________________________________________________________________________ CURRENT DRUGS AND MEDICATIONS____________________________________________ _____________________________________________________________________________ _____________________________________________________________________________ _____________________________________________________________________________ ALLERGIES___________________________________________________________________ _____________________________________________________________________________ MENSTRUAL AGE OF ONSET______CYCLE_____ (Number of days from start of one period to the start of the next) Length of periods_________________ Menstrual cramps [ ] Mild [ ] Moderate [ ] Severe Menstrual Flow [ ] Light [ ] Normal [ ] Heavy Pre-menstrual symptoms [ ] Yes [ ] No
PREGNANCIES Total Number_______ Number Full Term Births________ Premature births________ Miscarriages________ Abortions________ Number of Living Children____________ SOCIAL HISTORY Smoke Cigarettes [ ] Yes [ ] No How Much? __________ Drink alcohol [ ] Yes [ ] No How Much?_____________ Use drugs [ ] Yes [ ] No Type? ____________ How Often? _________ Birth control [ ] Yes [ ] No Type? _________ If Pills, Name_____________ Last pelvic exam______________ Last Pap smear___________ FAMILY HISTORY
[ ] Diabetes [ ] Tuberculosis [ ] Heart Disease [ ] Breast Cancer [ ] Ovarian Cancer (Both Partners) [ ] Cystic Fibrosis [ ] Hemophilia [ ] Tay-Sacks [ ] Mental Retardation [ ] Other Genetic TREATMENTS
[ ] Semen Analysis [ ] Tubal Dye Test [ ] Hormone Tests [ ] Post CoitalTest [ ] Clomid [ ] Other Fertility Drugs [ ] Insemination [ ] IVF [ ] ICSI [ ] PGD ANY OTHER PROBLEMS YOU WISH TO DISCUSS
[ ] Sexual problems [ ] Verbal/Physical Abuse [ ] Other______________________________________________________________________
ABSTRACTS Part “Oral & Dental Medicine” LABORATORY ABNORMALITIES IN PATIENTS WITH ORAL BURNING A.Krasteva*, A. Kisselova*, Vl. Panov**, V. Dineva*, A. Ivanova***, Z. Krastev*** * Faculty of Dental Medicine, Medical University, Sofia, Bulgaria ** Faculty of Dental Medicine, Medical University, Varna, Bulgaria ***Clinic of Gastroenterology, Hospital “Sveti Ivan Rilski”,
ARTYKU£Y I ROZPRAWY Prawo prywatnemiêdzynarodowe. Zasady wyboruprawa w³aœciwego dla du¿ychryzyk ubezpieczeniowych. Zagadnienia praktyczne 1. Wprowadzenie W dniu 16 maja 2011 r. wesz³a w ¿ycie ustawa z dnia 4 lutego 2011 r. – Pra- wo prywatne miêdzynarodowe 1 (dalej: Ustawa). Ustawa wprowadza zna- cz¹ce regulacje tak¿e dla obrotu ubezpieczeniowego, chocia¿ prima facie mog³
NAME____________________________________DATE______________________AGE_____